[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IS5223A - Lyfjasamsetningar af tizoxaníði og nitazoxaníði - Google Patents

Lyfjasamsetningar af tizoxaníði og nitazoxaníði

Info

Publication number
IS5223A
IS5223A IS5223A IS5223A IS5223A IS 5223 A IS5223 A IS 5223A IS 5223 A IS5223 A IS 5223A IS 5223 A IS5223 A IS 5223A IS 5223 A IS5223 A IS 5223A
Authority
IS
Iceland
Prior art keywords
tizoxanide
nitazoxanide
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
IS5223A
Other languages
English (en)
Other versions
IS2087B (is
Inventor
Rossignol Jean-François
Original Assignee
Romark Laboratories L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5223(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Application filed by Romark Laboratories L.C. filed Critical Romark Laboratories L.C.
Publication of IS5223A publication Critical patent/IS5223A/is
Publication of IS2087B publication Critical patent/IS2087B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS5223A 1997-05-07 1999-10-19 Lyfjasamsetningar af tizoxaníði og nitazoxaníði IS2087B (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (2)

Publication Number Publication Date
IS5223A true IS5223A (is) 1999-10-19
IS2087B IS2087B (is) 2006-03-15

Family

ID=27420362

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5223A IS2087B (is) 1997-05-07 1999-10-19 Lyfjasamsetningar af tizoxaníði og nitazoxaníði

Country Status (35)

Country Link
EP (2) EP1005342B1 (is)
JP (1) JP3739802B2 (is)
KR (2) KR100576646B1 (is)
CN (2) CN100515420C (is)
AP (1) AP1103A (is)
AR (1) AR057242A2 (is)
AT (2) ATE281166T1 (is)
AU (1) AU740022B2 (is)
BG (2) BG109365A (is)
BR (1) BR9808722A (is)
CA (2) CA2418634C (is)
CZ (2) CZ298270B6 (is)
DE (2) DE69827417T2 (is)
DK (2) DK1222921T3 (is)
EA (2) EA002920B1 (is)
EE (1) EE04870B1 (is)
ES (2) ES2232687T3 (is)
GE (1) GEP20032970B (is)
HK (1) HK1025907A1 (is)
HU (1) HU229641B1 (is)
IL (2) IL155799A (is)
IS (1) IS2087B (is)
LV (1) LV12492B (is)
ME (1) ME00530B (is)
NO (2) NO313983B1 (is)
NZ (2) NZ513881A (is)
OA (1) OA11169A (is)
PL (1) PL193275B1 (is)
PT (2) PT1005342E (is)
RO (1) RO120605B1 (is)
SI (1) SI20149B (is)
SK (2) SK283946B6 (is)
TR (1) TR199902733T2 (is)
UA (2) UA57079C2 (is)
WO (1) WO1998050035A1 (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
EA015560B1 (ru) * 2006-01-09 2011-08-30 Ромарк Лэборетериз, Эл.Си. Способ лечения вирусного гепатита
CN107260695A (zh) * 2009-02-13 2017-10-20 罗马克实验室有限公司 硝唑尼特的控制释放药物剂型
US8846727B2 (en) 2009-05-12 2014-09-30 Romark Laboratories, L.C. Haloalkyl heteroaryl benzamide compounds
CN108042535A (zh) 2009-06-26 2018-05-18 罗马克实验室有限公司 用于治疗流感的化合物和方法
WO2013110975A1 (es) 2012-01-27 2013-08-01 Siegfried Rhein S.A. De C.V. Composición de nitazoxanida mejorada y proceso para prepararla
KR20170081228A (ko) * 2014-11-11 2017-07-11 로마크 레버러토리즈, 엘.씨. 티족사나이드, 그의 유사체 또는 염의 전구 약물을 이용한 치료 조성물 및 방법
KR20200121816A (ko) 2018-02-02 2020-10-26 리플 테라퓨틱스 코포레이션 스테로이드 이량체를 포함하는 유리 제제 및 이의 용도
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
SI20149A (sl) 2000-08-31
ES2150404T1 (es) 2000-12-01
EA002908B1 (ru) 2002-10-31
NO20021832D0 (no) 2002-04-18
EP1005342A4 (en) 2001-02-07
CA2418634A1 (en) 1998-11-12
EE9900578A (et) 2000-08-15
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
DE69809928T2 (de) 2003-04-24
UA57079C2 (uk) 2003-06-16
KR100576646B1 (ko) 2006-05-08
LV12492A (en) 2000-06-20
BR9808722A (pt) 2000-07-11
BG103958A (en) 2000-07-31
HUP0003330A3 (en) 2002-10-28
CN1158074C (zh) 2004-07-21
IL132516A0 (en) 2001-03-19
HK1025907A1 (en) 2000-12-01
UA74388C2 (uk) 2005-12-15
NO995406L (no) 2000-01-04
NZ513881A (en) 2002-10-25
GEP20032970B (en) 2003-05-27
NO995406D0 (no) 1999-11-04
CZ391199A3 (cs) 2000-07-12
NO335781B1 (no) 2015-02-16
TR199902733T2 (xx) 2000-03-21
DK1005342T3 (da) 2003-03-24
ATE281166T1 (de) 2004-11-15
ME00530B (me) 2011-10-10
IL155799A (en) 2004-08-31
CA2288003A1 (en) 1998-11-12
EP1222921B1 (en) 2004-11-03
BG64973B1 (bg) 2006-11-30
SK283947B6 (sk) 2004-05-04
EP1222921A1 (en) 2002-07-17
AP1103A (en) 2002-09-04
CZ298269B6 (cs) 2007-08-08
KR20010020322A (ko) 2001-03-15
ES2150404T3 (es) 2003-07-01
EE04870B1 (et) 2007-08-15
EA002920B1 (ru) 2002-10-31
IS2087B (is) 2006-03-15
IL132516A (en) 2003-12-10
EA200100956A1 (ru) 2002-02-28
JP2001503067A (ja) 2001-03-06
PT1005342E (pt) 2003-02-28
ES2232687T3 (es) 2005-06-01
LV12492B (en) 2001-01-20
SI20149B (en) 2001-08-31
KR100426657B1 (ko) 2004-04-13
CN1255060A (zh) 2000-05-31
WO1998050035A1 (en) 1998-11-12
NO20021832L (no) 2000-01-04
CN100515420C (zh) 2009-07-22
OA11169A (en) 2003-04-25
SK283946B6 (sk) 2004-05-04
NO313983B1 (no) 2003-01-13
PT1222921E (pt) 2005-02-28
JP3739802B2 (ja) 2006-01-25
IL155799A0 (en) 2003-12-23
AU7289598A (en) 1998-11-27
ATE228839T1 (de) 2002-12-15
BG109365A (en) 2006-08-31
HUP0003330A2 (hu) 2001-05-28
CN1552322A (zh) 2004-12-08
DE69827417D1 (de) 2004-12-09
EP1005342B1 (en) 2002-12-04
PL336805A1 (en) 2000-07-17
CA2288003C (en) 2003-10-21
SK151199A3 (en) 2000-07-11
HU229641B1 (en) 2014-03-28
AR057242A2 (es) 2007-11-21
NZ500149A (en) 2001-11-30
KR20040004544A (ko) 2004-01-13
DK1222921T3 (da) 2005-03-07
EP1005342A1 (en) 2000-06-07
DE69809928D1 (de) 2003-01-16
PL193275B1 (pl) 2007-01-31
CZ298270B6 (cs) 2007-08-08
DE69827417T2 (de) 2005-10-27
RO120605B1 (ro) 2006-05-30
EA199901012A1 (ru) 2000-08-28
AU740022B2 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
DK0797431T3 (da) Aerosolformuleringer af peptider og proteiner
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
IS5245A (is) Lyfjablanda úr ómeprasól
NO20014219D0 (no) <Kappa>-agonist-forbindelser og farmasöytiske preparater derav
NO981967L (no) Stabile fryset°rkede farmas°ytiske formuleringer
NO20001914L (no) <alfa>-akryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
DK1001813T3 (da) Farmaceutiske formuleringer indeholdende voriconazol
NO993887D0 (no) Farmasöytiske formuleringer som innbefatter amoksycillin og clavulanat
DK0983251T3 (da) Anti-inflammatorisk piperazinylbenzyltetrazolderivater og mellemprodukter derfor
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
DK0994706T3 (da) Præparater til oral indgivelse af taxaner og anvendelse deraf
IS5223A (is) Lyfjasamsetningar af tizoxaníði og nitazoxaníði
ID16781A (id) Formulasi-formulasi farmasi
DK0905128T3 (da) Fremgangsmåder og mellemprodukter egnede til fremstilling af antifolater
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions
BR9605220A (pt) Gonadotropinas e composiçao farmacêutica
BR1100391A (pt) Composto e composição farmacêutica
SE9703737D0 (sv) Pharmaceutical composition and use
BR1101151A (pt) Compostos e composição farmacêutica
BR1100596A (pt) Composto e formulações farmacêuticas
ZA99887B (en) Pharmaceutical composition of hedgehog proteins and use thereof.
ZA995006B (en) Pharmaceutical composition of hedgehog proteins and use thereof.
NO974516D0 (no) Kreft og aids medisin: AXA